#1 Clinical Trials Search in Europe

Aztreonam

Aztreonam is an antibiotic medication that has been the subject of several clinical trials exploring its potential uses in treating various infections. This article summarizes key findings from recent clinical trials investigating aztreonam, particularly its inhaled formulation, for conditions like cystic fibrosis, bronchiectasis, and other bacterial infections. We’ll examine the drug’s efficacy, safety profile, and potential applications based on these clinical studies.

Table of Contents

What is Aztreonam?

Aztreonam is an antibiotic medication used to treat various bacterial infections. It belongs to a class of antibiotics called monobactams[9]. Aztreonam is also known by brand names such as Cayston, Azactam, and AZLI (Aztreonam Lysine for Inhalation)[2][3].

How Aztreonam Works

Aztreonam works by killing bacteria that cause infections. It does this by interfering with the bacteria’s ability to form cell walls, which are essential for their survival. This antibiotic is particularly effective against a type of bacteria called Gram-negative bacteria, which includes organisms like Pseudomonas aeruginosa[1].

Conditions Treated with Aztreonam

Aztreonam is used to treat various bacterial infections, including:

  • Cystic Fibrosis: A genetic disorder that affects the lungs and other organs. Aztreonam is often used to treat lung infections in people with cystic fibrosis[4].
  • Bronchiectasis: A condition where the airways of the lungs become damaged and widened. Aztreonam may be used to treat infections in people with this condition[5].
  • Gonorrhea: A sexually transmitted infection. Aztreonam is being studied as a potential treatment for gonorrhea, particularly infections in the throat[6].
  • Skin and Soft Tissue Infections: Aztreonam may be used in combination with other antibiotics to treat certain skin infections[7].
  • Tracheostomy Infections: Infections in people who have a surgical opening in their windpipe[8].

How Aztreonam is Administered

Aztreonam can be given in several ways, depending on the condition being treated:

  • Intravenous (IV) infusion: The medication is given directly into a vein through a needle or catheter[1].
  • Inhaled medication: For lung infections, aztreonam may be inhaled using a special nebulizer device. This allows the medication to be delivered directly to the lungs[2].
  • Intramuscular (IM) injection: The medication is injected into a muscle[6].

Effectiveness of Aztreonam

Clinical trials have shown that aztreonam can be effective in treating various bacterial infections. For example:

  • In people with cystic fibrosis, inhaled aztreonam has been shown to improve lung function and reduce the need for other antibiotics[4].
  • Studies are ongoing to determine if aztreonam can effectively treat gonorrhea infections, particularly in the throat[6].
  • Research is being conducted to see if aztreonam can help reduce infections in children with tracheostomy tubes[8].

Potential Side Effects

Like all medications, aztreonam can cause side effects. Some potential side effects include:

  • Cough
  • Respiratory tract congestion
  • Sore throat
  • Nasal congestion
  • Shortness of breath
  • Chest discomfort
  • Headache

These side effects are more commonly reported when aztreonam is inhaled[5]. It’s important to discuss potential side effects with your healthcare provider.

Ongoing Research on Aztreonam

Researchers are continuing to study aztreonam to understand its effectiveness in treating various conditions and to determine the best ways to use it. Some areas of ongoing research include:

  • Using aztreonam in combination with other antibiotics to treat severe infections[9].
  • Investigating the use of inhaled aztreonam for treating bronchiectasis[5].
  • Studying aztreonam as a potential treatment for gonorrhea infections[6].
  • Exploring the use of aztreonam to prevent infections in people with tracheostomy tubes[8].

As with any medication, it’s important to use aztreonam only as prescribed by your healthcare provider. They can provide more information about whether aztreonam is appropriate for your specific condition.

Aspect Details
Primary Conditions Studied Cystic Fibrosis, Bronchiectasis, Tracheostomy Infections, Acute Bacterial Skin and Skin Structure Infections
Main Formulations Inhaled Aztreonam Lysine (AZLI), Intravenous Aztreonam
Key Pathogens Targeted Pseudomonas aeruginosa, Gram-negative bacteria
Efficacy Measures Improvement in lung function, reduction in exacerbations, quality of life scores, bacterial load reduction
Safety Considerations Respiratory side effects (for inhaled form), renal function impact, combination with other antibiotics
Ongoing Research Areas Combination therapies (e.g., aztreonam-avibactam), dosing strategies, use in severe renal impairment

FAQ

  • What is aztreonam and how is it administered in clinical trials? Aztreonam is an antibiotic medication that belongs to the monobactam class. In clinical trials, it is often administered as an inhaled solution (aztreonam lysine for inhalation or AZLI) or intravenously. The inhaled form is typically used for respiratory infections, while the intravenous form may be used for various bacterial infections.
  • What conditions are being studied using aztreonam in clinical trials? Clinical trials are investigating aztreonam for various conditions, including cystic fibrosis, bronchiectasis, tracheostomy infections, acute bacterial skin and skin structure infections, and infections in patients with severe renal impairment. It is particularly studied for its effectiveness against Pseudomonas aeruginosa infections.
  • How effective is aztreonam in treating cystic fibrosis? Clinical trials have shown that inhaled aztreonam can be effective in treating cystic fibrosis patients with Pseudomonas aeruginosa infections. It has been found to improve respiratory symptoms, lung function, and quality of life in some studies. However, effectiveness may vary among individuals.
  • What are the potential side effects of aztreonam? Common side effects of inhaled aztreonam may include cough, respiratory tract congestion, sore throat, nasal congestion, and wheezing. For intravenous aztreonam, side effects can include injection site reactions. As with any medication, the full range of potential side effects should be discussed with a healthcare provider.
  • Are there ongoing studies combining aztreonam with other drugs? Yes, there are ongoing studies investigating combinations of aztreonam with other drugs. For example, some trials are looking at aztreonam-avibactam combinations for various infections, and others are exploring the use of aztreonam with drugs like colistin for treating cystic fibrosis exacerbations.

Ongoing Clinical Trials on Aztreonam

  • Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

    Recruiting

    1 1 1
    Investigated drugs:
    Norway Sweden

  • Study on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Croatia Czechia Estonia France Greece +9

  • Study of Aztreonam-Avibactam and Metronidazole for Children with Serious Gram-Negative Bacterial Infections

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Greece Hungary Spain

  • Testing Antibiotic Treatment Strategies for Patients with Bladder Bacteria Without Symptoms Receiving Botulinum Toxin A Bladder Injections

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of antibiotic treatment effectiveness in critically ill patients receiving drug combination therapy

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on Aztreonam, Avibactam, and Metronidazole for Treating Infections in Neonates and Infants Under 9 Months with Gram-Negative Bacterial Infections

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Greece Hungary Italy Slovakia Spain

  • Study of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections

    Not recruiting

    1 1 1
    Investigated drugs:
    Bulgaria Greece Latvia Lithuania Poland Portugal +2

  • Study on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Resistant Bacterial Infections

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Croatia Czechia France Greece Latvia Slovakia +1

  • Study on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Bulgaria Czechia Estonia Latvia Lithuania Slovakia

Glossary

  • Aztreonam: An antibiotic belonging to the monobactam class, used to treat various bacterial infections, particularly those caused by gram-negative organisms like Pseudomonas aeruginosa.
  • AZLI: Aztreonam Lysine for Inhalation, a formulation of aztreonam designed for inhalation, often used in the treatment of respiratory infections in conditions like cystic fibrosis.
  • Cystic Fibrosis (CF): A genetic disorder that affects mostly the lungs, but also the pancreas, liver, kidneys, and intestine. It is characterized by abnormal secretions leading to mucus buildup.
  • Bronchiectasis: A chronic condition where the airways of the lungs become abnormally widened, leading to a build-up of excess mucus that can make the lungs more vulnerable to infection.
  • Pseudomonas aeruginosa: A common type of bacteria that can cause infections in humans, particularly in those with weakened immune systems or certain chronic lung conditions.
  • Exacerbation: A worsening of symptoms or an increase in the severity of a disease, often used in the context of chronic respiratory conditions.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Renal Impairment: A condition where the kidneys are not functioning properly, which can affect how drugs are processed and eliminated from the body.
  • Bacterial Load: The amount of bacteria present in an infection, often measured to assess the effectiveness of antibiotic treatments.
  • Quality of Life (QoL): A measure of an individual's well-being and ability to perform daily activities, often used as an outcome in clinical trials to assess the impact of treatments.

References

  1. https://clinicaltrials.gov/study/NCT04486625
  2. https://clinicaltrials.gov/study/NCT02730793
  3. https://clinicaltrials.gov/study/NCT02894684
  4. https://clinicaltrials.gov/study/NCT00989807
  5. https://clinicaltrials.gov/study/NCT03696290
  6. https://clinicaltrials.gov/study/NCT03867734
  7. https://clinicaltrials.gov/study/NCT01984684
  8. https://clinicaltrials.gov/study/NCT03158116
  9. https://clinicaltrials.gov/study/NCT03978091